LncRNA LINC00511 promotes COL1A1-mediated proliferation and metastasis by sponging miR-126-5p/miR-218-5p in lung adenocarcinoma
Authors:
Open Access
- 16 July 2022
- journal article
- research article
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 22 (1) , 1-15
Abstract
Background: Lung adenocarcinoma (LUAD) is currently the leading cause of cancer-related death worldwide. Long noncoding RNAs (lncRNAs) play key roles in tumor occurrence and development as crucial cancer regulators. The present study aimed to explore the molecular mechanism and regulatory network of Linc00511 in LUAD and to identify new potential therapeutic targets for LUAD. Methods: Real-time quantitative polymerase chain reaction (RT–qPCR) was performed to determine the relative Linc00511 levels in LUAD tissues and cells. The proliferation, apoptosis, migration, and invasion abilities of LUAD cells were assessed by a Cell Counting Kit-8 (CCK-8) assay, a colony formation assay, flow cytometry, and a Transwell assay. Changes in hsa_miR-126-5p, hsa_miR-218-5p, and COL1A1 expression were analyzed using western blotting and RT–qPCR. Targeted binding between miR-126-5p/miR-218-5p and Linc00511 or COL1A1 was verified with a luciferase reporter system and confirmed by an RNA pulldown assay. The participation of the PI3K/AKT signaling pathway was confirmed via western blotting. Xenograft animal experiments were performed to detect the impact of Linc00511 on LUAD tumor growth in vivo. Results: In the present work, we observed that Linc00511 was upregulated in LUAD tissues and cells. Loss/gain-of-function experiments indicated that knockdown of Linc00511 significantly inhibited LUAD cell proliferation, migration and invasion and promoted LUAD cell apoptosis, whereas overexpression of Linc00511 showed the opposite effects. In addition, we determined that Linc00511 promoted COL1A1-mediated cell proliferation and cell motility by sponging miR-126-5p and miR-218-5p. Moreover, Linc00511 activated the PI3K/AKT signaling pathway through upregulation of COL1A1. Finally, silencing of Linc00511 inhibited LUAD tumor growth in vivo. Conclusions: Linc00511 acts as a competing endogenous RNA to regulate COL1A1 by targeting miR-126-5p and miR-218-5p, thereby promoting the proliferation and invasion of LUAD cells.Keywords
This publication has 41 references indexed in Scilit:
- Development of a miRNA-seq based prognostic signature in lung adenocarcinomaBMC Cancer, 2019
- LncRNA Linc00511 promotes osteosarcoma cell proliferation and migration through sponging miR‐765Journal of Cellular Biochemistry, 2018
- Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axisJournal of Experimental & Clinical Cancer Research, 2018
- The clinical significance of miR-335, miR-124, miR-218 and miR-484 downregulation in gastric cancerMolecular Biology Reports, 2018
- The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinomaMolecular Cancer, 2018
- Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa‐miR‐29b‐3p in pancreatic ductal adenocarcinomaJournal of Cellular and Molecular Medicine, 2017
- MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosisMolecular Cancer, 2017
- Identification of microRNAs as potential biomarkers for lung adenocarcinoma using integrating genomics analysisOncotarget, 2017
- COL1A1, PRPF40A, and UCP2 correlate with hypoxia markers in non-small cell lung cancerJournal of Cancer Research and Clinical Oncology, 2017
- A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?Cell, 2011